Web Results

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2014cv01317/55946/389

Jan 3, 2017 ... Amgen Inc. et al v. Sanofi et al, No. 1:2014cv01317 - Document 389 (D. Del. 2017) case opinion from the District of Delaware US Federal District Court.

www.law360.com/articles/878098/amgen-wins-injunction-on-sale-of-sanofi-s-cholesterol-drug

Jan 5, 2017 ... Sanofi and Regeneron Pharmaceuticals must stop selling the cholesterol- lowering drug Praluent after a Delaware federal judge entered a permanent injunction in favor of Amgen ... The case is Amgen Inc. et al. v. Sanofi et al., case number 1:14-cv-01317, in the U.S. District Court for the District of Delaware.

www.pacermonitor.com/public/case/24094360/Washington_et_al_v_Accord_Healthcare,_Inc_et_al

Mar 30, 2018 ... Monday, April 02, 2018. 3, 3 service Summons Issued Mon 3:52 PM Summons Issued as to Accord Healthcare, Inc., Actavis LLC, Actavis Pharma, Inc., Hospira Worldwide, LLC, Hospira, Inc., McKesson Corporation, Pfizer Inc., Sandoz, Inc., Sanofi US Services Inc., Sanofi-Aventis U.S. LLC, Sun Pharma ...

www.jpml.uscourts.gov/sites/jpml/files/Hearing_Order-3-30-2017.pdf

Mar 30, 2017 ... Pursuant to the order of the United States Judicial Panel on Multidistrict Litigation filed today, notice is hereby given that a .... Northern District of Alabama. BRIDGES, ET AL. v. BAYER HEALTHCARE PHARMACEUTICALS, INC., ET AL.,. C.A. No. 2:14!00036. Eastern District of California. PATTERSON v.

www.hausfeld.com/news-press/no-safe-harbor

Aug 12, 2016 ... On May 4, 2016, the Third Circuit—following the principles it set forth in LePage's, [1] Dentsply,[2] and ZF Meritor[3]—affirmed a decision by District of New Jersey Judge Mary L. Cooper granting summary judgment in favor of the defendant in Eisai, Inc. v. Sanofi-Aventis U.S., LLC.[4] Eisai is the latest in a line ...

www.goodwinlaw.com/professionals/r/rein-frederick

He is a U.S. registered patent attorney with over 25 years of experience at the intersection of technology and law. Areas of Practice .... “Sanofi-Aventis et al. v. Apotex Inc. et al.: The one hundred eight million dollar question,” Journal of Generic Medicines (May 24, 2012). “Unigene Laboratories, Inc. et al. v. Apotex, Inc. et al.

petrieflom.law.harvard.edu/assets/publications/Sachs_Rachel_in_Sanofi_Federal_Appeal_2017.pdf

Jan 13, 2017 ... v. SANOFI, SANOFI-AVENTIS U.S. LLC, AVENTISUB LLC, f/d/b/a AVENTIS. PHARMACEUTICALS INC., and REGENERON PHARMACEUTICALS, INC., ...... IN THE UNITED STATES DISTRICT COURT. FOR THE DISTRICT OF DELAWARE. AMGEN INC., et al.,. Plaintiffs, v. SANOFI, et al.,. Defendants.

www.weil.com/litigation-wins

We take pride in the achievements of attorneys across all of our global litigation practices, who exhibited the tenacity and creativity that our clients expect as we partner with them to tackle their most complex business disputes. Our digital companion microsite ... Fidelity National Financial and Lender Processing Services, Inc.

www.analysisgroup.com/uploadedfiles/content/experts_and_staff/managing_principals/mulhern_cv.pdf

Amgen, Inc. v. Sanofi, Sanofi-Aventis U.S., LLC, Aventisub, LLC, f/d/b/a/ Aventis. Pharmaceuticals, Inc., and Regeneron Pharmaceuticals, Inc. U.S. District Court ..... Touchcom v. Bereskin & Parr et al. U.S. District Court, Eastern District of Virginia. Professional negligence: expert report (2010) and deposition testimony ( 2010) ...